top of page

— THE PROBLEM

Most market entry fails not because the product is wrong — but because the assumptions that built the existing model were never designed to be questioned.

Entering a market your organization has never served requires an honest assessment of what you actually have — and what you don't. In most new market entries, up to 50 percent of existing assets are genuinely deployable. The rest must be partnered, built, and/or acquired. Getting that ratio wrong is the most common and most expensive mistake in market entry.

Vaxa designs the entry in phases — identifying which assets travel, filling the gaps through the right combination of partnerships, builds, and acquisitions, and sequencing the channel, customers, and commercial model before capital is committed to execution.

The asset audit that changes the entry design

Which capabilities, relationships, technologies, and channels are genuinely transferable to the new market — and which only appear to be. Most organizations overestimate both.

Gaps filled in the right sequence

What cannot be transferred must be partnered, built, or acquired. Vaxa determines which mechanism is right for each gap — and in what order — before the entry begins.

A phased entry, not a single bet

New market entry that tries to do everything at once rarely survives first contact. Vaxa designs the phases — what moves first, what follows, and what the triggers are for each step.

"In most new market entries, 10 to 50 percent of what you have is genuinely deployable. The rest must be partnered, built, or acquired — and always in phases. Getting that ratio wrong is the most expensive mistake in market entry."

— CLIENT OUTCOMES

A market entry built on what you have — and designed for what you don't.

01

Clarity on which assets actually travel

A structured, honest assessment of which existing capabilities, relationships, technologies, and channels are genuinely deployable in the new market — and which only appear to be. Most organizations overestimate both. This assessment changes the entry design before capital is committed.

Entry designed on actual transferable assets, not assumed ones

02

A gap-filling strategy that uses the right mechanism

What cannot be transferred must be partnered, built, or acquired. Vaxa determines which mechanism is right for each gap — and in what order. The wrong mechanism for the wrong gap at the wrong time is the second most common failure point in new market entry.

Each gap addressed through the right partner, build, or acquisition path

03

A phased entry with defined triggers

New market entry that tries to do everything at once rarely survives first contact. Vaxa designs the phases — what moves first, what follows, and what the commercial and competitive triggers are before each step is taken. The entry is a sequence, not a single bet.

Entry sequenced in phases with clear triggers between each

04

The first customers before the entry scales

The specific organizations most likely to convert first, the commercial model that makes the first transaction possible, and the approach to reach them before the broader entry begins. Early customers in a new market are not a scale problem — they are a design problem.

First customer pipeline defined and sequenced before execution starts

Emerging & New Markets

Entering a market your model was never built to serve is not a scaling problem. It's a design problem.

The organizations that get this right don't move faster. They move differently — with a structure designed for the new market, not just adapt from the old one.

— WHAT WE DO

Three types of work

01

Asset Alignment & Gap Analysis

A structured assessment of which existing capabilities, relationships, technologies, and channels are genuinely deployable in the new market — and a clear map of what is missing. The foundation every entry design is built on.

02

Entry Architecture & Phase Design

The full entry design built in phases — channel model, partner ecosystem, build vs. buy decisions, customer sequence, and competitive positioning. Sequenced for the new market, not the existing one. Each phase has defined triggers before the next begins.

03

First Customer Strategy

Identification of the specific organizations most likely to convert first, the approach to reach them, and the commercial model that makes the first transaction possible. The sequence of early customers matters as much as the strategy — Vaxa designs both.

Stay ahead of what's forming. Subscribe to Vaxa Insights — our look at the critical issues and emerging opportunities facing businesses today.

—  GROWTH STRATEGY • EMERGING NEW MARKETS

Your existing assets are stronger in new markets than you think

The organizations that win in new markets don't start over — they know exactly which assets travel and which don't, and how to acquire new ones.

LET'S TALK
bottom of page